Literature DB >> 26537681

Correlation between Virus Replication and Antibody Responses in Macaques following Infection with Pandemic Influenza A Virus.

Gerrit Koopman1, Petra Mooij2, Liesbeth Dekking3, Daniëlla Mortier1, Ivonne G Nieuwenhuis1, Melanie van Heteren1, Harmjan Kuipers3, Edmond J Remarque4, Katarina Radošević3, Willy M J M Bogers1.   

Abstract

UNLABELLED: Influenza virus infection of nonhuman primates is a well-established animal model for studying pathogenesis and for evaluating prophylactic and therapeutic intervention strategies. However, usually a standard dose is used for the infection, and there is no information on the relation between challenge dose and virus replication or the induction of immune responses. Such information is also very scarce for humans and largely confined to evaluation of attenuated virus strains. Here, we have compared the effect of a commonly used dose (4 × 10(6) 50% tissue culture infective doses) versus a 100-fold-higher dose, administered by intrabronchial installation, to two groups of 6 cynomolgus macaques. Animals infected with the high virus dose showed more fever and had higher peak levels of gamma interferon in the blood. However, virus replication in the trachea was not significantly different between the groups, although in 2 out of 6 animals from the high-dose group it was present at higher levels and for a longer duration. The virus-specific antibody response was not significantly different between the groups. However, antibody enzyme-linked immunosorbent assay, virus neutralization, and hemagglutination inhibition antibody titers correlated with cumulative virus production in the trachea. In conclusion, using influenza virus infection in cynomolgus macaques as a model, we demonstrated a relationship between the level of virus production upon infection and induction of functional antibody responses against the virus. IMPORTANCE: There is only very limited information on the effect of virus inoculation dose on the level of virus production and the induction of adaptive immune responses in humans or nonhuman primates. We found only a marginal and variable effect of virus dose on virus production in the trachea but a significant effect on body temperature. The induction of functional antibody responses, including virus neutralization titer, hemagglutination inhibition titer, and antibody-dependent cell-mediated cytotoxicity, correlated with the level of virus replication measured in the trachea. The study reveals a relationship between virus production and functional antibody formation, which could be relevant in defining appropriate criteria for new influenza virus vaccine candidates.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26537681      PMCID: PMC4702706          DOI: 10.1128/JVI.02757-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children.

Authors:  Steven Black; Uwe Nicolay; Timo Vesikari; Markus Knuf; Giuseppe Del Giudice; Giovanni Della Cioppa; Theodore Tsai; Ralf Clemens; Rino Rappuoli
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

2.  Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans.

Authors:  Tom M Wilkinson; Chris K F Li; Cecilia S C Chui; Arthur K Y Huang; Molly Perkins; Julia C Liebner; Rob Lambkin-Williams; Anthony Gilbert; John Oxford; Ben Nicholas; Karl J Staples; Tao Dong; Daniel C Douek; Andrew J McMichael; Xiao-Ning Xu
Journal:  Nat Med       Date:  2012-01-29       Impact factor: 53.440

3.  Effect of an asparagine-to-serine mutation at position 294 in neuraminidase on the pathogenicity of highly pathogenic H5N1 influenza A virus.

Authors:  Maki Kiso; Makoto Ozawa; Mai Thi Quynh Le; Hirotaka Imai; Kei Takahashi; Satoshi Kakugawa; Takeshi Noda; Taisuke Horimoto; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

4.  Human influenza resulting from aerosol inhalation.

Authors:  R H Alford; J A Kasel; P J Gerone; V Knight
Journal:  Proc Soc Exp Biol Med       Date:  1966-07

5.  A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses.

Authors:  G F Rimmelzwaan; M Baars; G van Amerongen; R van Beek; A D Osterhaus
Journal:  Vaccine       Date:  2001-10-12       Impact factor: 3.641

6.  Comparison of the FilmArray RP, Verigene RV+, and Prodesse ProFLU+/FAST+ multiplex platforms for detection of influenza viruses in clinical samples from the 2011-2012 influenza season in Belgium.

Authors:  Liesbeth Van Wesenbeeck; Hanne Meeuws; Andrea Van Immerseel; Gabriela Ispas; Kristiane Schmidt; Lieselot Houspie; Marc Van Ranst; Lieven Stuyver
Journal:  J Clin Microbiol       Date:  2013-07-03       Impact factor: 5.948

7.  Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus.

Authors:  Dominick J Laddy; Jian Yan; Amir S Khan; Hanne Andersen; Amanda Cohn; Jack Greenhouse; Mark Lewis; Jody Manischewitz; Lisa R King; Hana Golding; Ruxandra Draghia-Akli; David B Weiner
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

8.  Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain.

Authors:  B R Murphy; H P Holley; E J Berquist; M M Levine; S B Spring; H F Maassab; A P Kendal; R M Chanock
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

9.  Course of seasonal influenza A/Brisbane/59/07 H1N1 infection in the ferret.

Authors:  Alexis McBrayer; Jeremy V Camp; Ron Tapp; Vladimir Yamshchikov; Sheila Grimes; Diana L Noah; Colleen B Jonsson; Carl E Bruder
Journal:  Virol J       Date:  2010-07-09       Impact factor: 4.099

10.  Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates.

Authors:  Shufang Fan; Yuwei Gao; Kyoko Shinya; Chris Kafai Li; Yanbing Li; Jianzhong Shi; Yongping Jiang; Yongbing Suo; Tiegang Tong; Gongxun Zhong; Jiasheng Song; Ying Zhang; Guobin Tian; Yuntao Guan; Xiao-Ning Xu; Zhigao Bu; Yoshihiro Kawaoka; Hualan Chen
Journal:  PLoS Pathog       Date:  2009-05-01       Impact factor: 6.823

View more
  8 in total

Review 1.  Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design.

Authors:  Sinthujan Jegaskanda; Hillary A Vanderven; Adam K Wheatley; Stephen J Kent
Journal:  Hum Vaccin Immunother       Date:  2017-03-23       Impact factor: 3.452

2.  Immunization and Drug Metabolizing Enzymes: Focus on Hepatic Cytochrome P450 3A.

Authors:  Kristina Jonsson-Schmunk; Romi Ghose; Maria A Croyle
Journal:  Expert Rev Vaccines       Date:  2021-03-18       Impact factor: 5.217

3.  Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness.

Authors:  Gro Tunheim; Ida Laake; Anna Hayman Robertson; Kristian Waalen; Olav Hungnes; Lisbeth M Naess; Rebecca J Cox; Siri Mjaaland; Lill Trogstad
Journal:  Influenza Other Respir Viruses       Date:  2019-01-01       Impact factor: 4.380

4.  Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2.

Authors:  Petra Mooij; Juan García-Arriaza; Patricia Pérez; Adrian Lázaro-Frías; Babs E Verstrepen; Kinga P Böszörményi; Daniella Mortier; Zahra Fagrouch; Gwendoline Kiemenyi-Kayere; Henk Niphuis; Roja Fidel Acar; Lisette Meijer; Marieke A Stammes; Ivanela Kondova; Ernst J Verschoor; Corine H GeurtsvanKessel; Erwin de Bruin; Reina S Sikkema; Joanna Luczkowiak; Rafael Delgado; Dolores Montenegro; Eugenia Puentes; Esteban Rodríguez; Willy M J M Bogers; Gerrit Koopman; Mariano Esteban
Journal:  Front Immunol       Date:  2022-03-16       Impact factor: 7.561

5.  Influenza A Virus Challenge Models in Cynomolgus Macaques Using the Authentic Inhaled Aerosol and Intra-Nasal Routes of Infection.

Authors:  Anthony C Marriott; Mike Dennis; Jennifer A Kane; Karen E Gooch; Graham Hatch; Sally Sharpe; Claudia Prevosto; Gail Leeming; Elsa-Gayle Zekeng; Karl J Staples; Graham Hall; Kathryn A Ryan; Simon Bate; Nathifa Moyo; Catherine J Whittaker; Bassam Hallis; Nigel J Silman; Ajit Lalvani; Tom M Wilkinson; Julian A Hiscox; James P Stewart; Miles W Carroll
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

6.  Heterosubtypic immunity increases infectious dose required to infect Mallard ducks with Influenza A virus.

Authors:  Karen M Segovia; Monique S França; Christina L Leyson; Darrell R Kapczynski; Klaudia Chrzastek; Charlie S Bahnson; David E Stallknecht
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

7.  Exploring the impact of inoculum dose on host immunity and morbidity to inform model-based vaccine design.

Authors:  Andreas Handel; Yan Li; Brian McKay; Kasia A Pawelek; Veronika Zarnitsyna; Rustom Antia
Journal:  PLoS Comput Biol       Date:  2018-10-01       Impact factor: 4.475

Review 8.  Back to the Future for Influenza Preimmunity-Looking Back at Influenza Virus History to Infer the Outcome of Future Infections.

Authors:  Magen Ellen Francis; Morgan Leslie King; Alyson Ann Kelvin
Journal:  Viruses       Date:  2019-01-30       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.